Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University Hospital Heidelberg
Emory University
Hoffmann-La Roche
Pfizer
Neonc Technologies, Inc.
Shanghai Chest Hospital
Cancer Research UK
MedSIR
Essen Biotech
Mayo Clinic
Wake Forest University Health Sciences
University Hospital, Bordeaux
Novartis
Pfizer
Iambic Therapeutics, Inc
Tango Therapeutics, Inc.
Amgen
Guangzhou Medical University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
xCures
Tianjin Medical University Cancer Institute and Hospital
University of Pittsburgh
Guangzhou University of Traditional Chinese Medicine
Orano Med LLC
Zhejiang Cancer Hospital
NRG Oncology
NRG Oncology
Eli Lilly and Company
Dysplasia Diagnostics Limited
Tianjin Medical University Cancer Institute and Hospital
University of Washington
InSightec
City of Hope Medical Center
Wayshine Biopharm, Inc.
National Cancer Institute (NCI)
Cancer Research UK
Sun Yat-sen University
M.D. Anderson Cancer Center
NovoCure Ltd.
Pfizer
Incyte Corporation
Eli Lilly and Company
Taiho Oncology, Inc.
University of Arizona
National Cancer Institute (NCI)
Day One Biopharmaceuticals, Inc.
Hadassah Medical Organization
Latin American Cooperative Oncology Group